ASCO-GU Interview | Dr. Antonio Cigliola: Utility of FDG-PET to predict a pelvic lymph node involvement (LNI) in patients (pts) with MIBC enrolled in neoadjuvant therapy trials.
Editor's note: Recently, ASCO-GU, the top event in the field of genitourinary cancers, was held in San Francisco, USA. During the meeting, Dr. Antonio Cigliola shared a study on using…